127 related articles for article (PubMed ID: 32276789)
1. Clinicopathological significance of olfactomedin-4 in extrahepatic bile duct carcinoma.
Jun SY; An S; Huh T; Chung JY; Hong SM
Pathol Res Pract; 2020 May; 216(5):152940. PubMed ID: 32276789
[TBL] [Abstract][Full Text] [Related]
2. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases.
Nakanishi Y; Zen Y; Kawakami H; Kubota K; Itoh T; Hirano S; Tanaka E; Nakanuma Y; Kondo S
Mod Pathol; 2008 Jul; 21(7):807-16. PubMed ID: 18425077
[TBL] [Abstract][Full Text] [Related]
5. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
Jang BG; Lee BL; Kim WH
Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N
Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of S100 protein expression in cholangiocarcinoma.
Sato Y; Harada K; Sasaki M; Nakanuma Y
J Gastroenterol Hepatol; 2013 Aug; 28(8):1422-9. PubMed ID: 23621473
[TBL] [Abstract][Full Text] [Related]
8. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
Nakanuma Y; Uchida T; Sato Y; Uesaka K
Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
[TBL] [Abstract][Full Text] [Related]
9. Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections - special reference to its association with lymph node metastases-.
Inoue T; Eguchi T; Oda Y; Nishiyama K; Fujii K; Izumi H; Kohno K; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2007 Feb; 20(2):267-76. PubMed ID: 17361208
[TBL] [Abstract][Full Text] [Related]
10. The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location.
Ishida K; Osakabe M; Eizuka M; Tai S; Sugimoto R; Fujita Y; Katagiri H; Takahara T; Uesugi N; Nitta H; Sasaki A; Sugai T
Hum Pathol; 2019 Oct; 92():91-100. PubMed ID: 31401234
[TBL] [Abstract][Full Text] [Related]
11. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
12. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression in extrahepatic cholangiocarcinoma.
Walter D; Herrmann E; Schnitzbauer AA; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
Histopathology; 2017 Sep; 71(3):383-392. PubMed ID: 28419539
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
Chu X; Zhao P; Lv Y; Liu L
Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
[TBL] [Abstract][Full Text] [Related]
15. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.
Luo Z; Zhang Q; Zhao Z; Li B; Chen J; Wang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1713-20. PubMed ID: 21904905
[TBL] [Abstract][Full Text] [Related]
16. DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.
Goeppert B; Roessler S; Becker N; Zucknick M; Vogel MN; Warth A; Pathil-Warth A; Mehrabi A; Schirmacher P; Mollenhauer J; Renner M
Histopathology; 2017 Jun; 70(7):1064-1071. PubMed ID: 28130841
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas.
Sawada R; Ku Y; Akita M; Otani K; Fujikura K; Itoh T; Ajiki T; Fukumoto T; Kakeji Y; Zen Y
Histopathology; 2018 Aug; 73(2):259-272. PubMed ID: 29675965
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
19. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
